SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021584
Filing Date
2018-08-14
Accepted
2018-08-14 08:31:37
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scph-10q_20180630.htm 10-Q 1080460
2 EX-31.1 scph-ex311_9.htm EX-31.1 10768
3 EX-31.2 scph-ex312_8.htm EX-31.2 10552
4 EX-32.1 scph-ex321_6.htm EX-32.1 8085
5 EX-32.2 scph-ex322_7.htm EX-32.2 7984
  Complete submission text file 0001564590-18-021584.txt   4228208

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scph-20180630.xml EX-101.INS 862013
7 XBRL TAXONOMY EXTENSION SCHEMA scph-20180630.xsd EX-101.SCH 36768
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20180630_cal.xml EX-101.CAL 41993
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20180630_def.xml EX-101.DEF 103040
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20180630_lab.xml EX-101.LAB 279540
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20180630_pre.xml EX-101.PRE 210458
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 181014435
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1